Absci, a data-first generative AI drug-creation company, is partnering with AMD, a semiconductor company, to deploy AMD Instinct accelerators and ROCm software to power vital AI drug-discovery workloads, as well as Absci's advanced De Novo antibody-design models.
In addition, AMD is making a $20 million investment in Absci. The investment will be structured as a private investment in public...
On his first day in office of his second term, President Donald Trump revoked Joe Biden's 2023 executive order, which aimed to establish standards for the safe, secure and trustworthy development of AI across various sectors, including healthcare.
Among its many provisions, Biden's order directed the U.S. Department of Health and Human Services (HHS) to establish a safety program "to help ensure...
Cornerstone Robotics bags $70M Series C funding
Surgical robotics maker Cornerstone Robotics from Hong Kong has raised over $70 million in a Series C funding round led by EQT. It also received additional investment from the Hong Kong government's Innovation and Technology Venture Fund.
The company, established in 2019, will use its fresh funds to expand into key global markets in Europe and...
At a Boston Consulting Group (BCG) event in San Francisco during the JPM Healthcare Conference taking place this week, panelists discussed the government's role in advancing AI technology and government oversight of the technology with the changing administration.
Micky Tripathi, assistant secretary for technology policy, national coordinator for health IT and chief AI officer for the U.S....
Researchers from The Chinese University of Hong Kong and Beijing Tongren Hospital have developed a foundational AI model for automated eye disease diagnosis.
WHAT IT'S ABOUT
The generative AI model, VisionFM, was pre-trained on a large ophthalmic data cohort containing 3.4 million images from over 500,000 individuals worldwide. The pre-training dataset covers eight eye imaging modalities,...
Back-to-back news over the past few years since the recent pandemic reported on the aggressive global expansion of South Korean companies in the medical imaging AI space.
From securing regulatory approvals to closing national and regional-scale distribution and partnerships, these innovators (such as Lunit, VUNO, and Coreline Soft) seemed to have convinced health systems worldwide of the...
Drug discovery startup Insilico Medicine and Italian pharmaceutical company Menarini Group announced their second licensing agreement, which targets unmet needs in oncology with a novel AI-discovered preclinical asset.
The agreement grants Stemline Therapeutics, a subsidiary of Menarini, global rights to develop and commercialize a selective small molecule inhibitor with broad antitumor activity...
Qventus, which offers health systems an AI-based care automation platform, has garnered $105 million in Series D funding in a round led by KKR.
Bessemer Venture Partners also participated in the round alongside new strategic investors HonorHealth, Northwestern Medicine and Allina Health.
Mudit Garg, CEO of Qventus, sat down with MobiHealthNews during the JPM Healthcare Conference to discuss the...
San Francisco-based health data analytics company Innovaccer scored $275 million in a Series F funding round, which was a combination of primary and secondary funding.
The round brings the company's total funding to $675 million.
WHAT IT DOES
Innovaccer, founded in 2014, works with life sciences companies, government organizations, providers and payers.
Its Healthcare Intelligence Cloud is a...
South Korean wearable robot heads to US
WIRobotics, a robotics manufacturer from South Korea, is set to launch its wearable gait assistance robot in the United States.
Called WIM (We Innovate Mobility), the wearable exoskeleton, launched last year, features different modes: assist, resist, hike, and slow walk. It comes with a companion mobile application that provides analysis of gait, including...
